A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

NCT06544655 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: BMS-986484
BIOLOGICAL: Nivolumab
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Fluorouracil
DRUG: Calcium folinate

Sponsor

Bristol-Myers Squibb